The authorized shares are now 22,675 times the issued shares. That is not a rounding error. It is a structural signal. On August 14, shareholders of SOLAI Limited—formerly BIT Mining, now self-styled as a “Solana treasury company”—approved a capital restructuring that included a 700:1 reverse stock split and an expansion of authorized shares to 100 billion. The company’s current issued shares post-split? Approximately 4.41 million. The ratio is extreme. The math is the truth. The narrative is the distraction.
Context
SOLAI Limited is a micro-cap entity that pivoted from bitcoin mining to holding Solana (SOL) assets as a corporate treasury. The company’s ticker once traded on the NYSE American under the symbol “BTCM.” In June 2024, the NYSE suspended trading because the company’s market capitalization fell below the $15 million continued listing standard. SOLAI did not appeal. The stock now trades on the OTC Pink market under the symbol “SLAIY.” The company’s transformation from a mining operator to a Solana Treasury vehicle was accompanied by a series of equity issuances: in June 2024, SOLAI issued 1.16 billion shares (pre-split) as consideration for an acquisition. The recent capital restructuring, approved at a special shareholder meeting on August 14, 2024, formalized a 700:1 reverse split and a massive increase in authorized shares. The pre-split authorized share count was 38.4 billion. The company first increased that to 70 trillion, then after the reverse split, the authorized count became 100 billion. The entire process was approved by shareholders, but the critical question—what the new authorized shares will be used for—remains unanswered.

Core
The core of this analysis is the structural risk embedded in the authorized share expansion. The ratio of authorized to issued shares is 22,675:1. For context, a typical U.S. listed company maintains authorized shares at 1.5 to 3 times the issued count. A ratio above 10 is considered a red flag. SOLAI’s ratio is over 7,500 times that threshold. This is not a reserve for future employee stock options or a modest acquisition war chest. It is a license to print shares.
Based on my audit experience, I have seen capital structures designed to mask dilution. But this is in a different league. The authorized share count of 100 billion—compared to 4.41 million issued—means that if all authorized shares were issued, each existing share would be diluted to 0.0044% of its current ownership stake. The company has not disclosed any specific purpose for the new authorized shares. The press release from August 17, 2024, stated only that the restructuring was “to provide the Company with greater flexibility in future financing and strategic transactions.” That is corporate boilerplate. The real flexibility is for the board to issue stock without further shareholder approval, up to 100 billion shares. This is not a capital restructuring. It is a structural pre-commitment to dilution.
Furthermore, the company has not clarified how the American Depositary Shares (ADS) will be adjusted post-split. The ADS ratio is a critical piece of information for holders. Without it, investors cannot accurately calculate their economic interest. The silence is a red flag. Complexity hides the body. The 700:1 reverse split and the roundabout authorized share increase—from 38.4 billion to 70 trillion to 100 billion—is a mechanism that obfuscates the true impact. The average retail shareholder cannot easily compute the dilution effect. The company is betting on that confusion.
Contrarian
A bull might argue that the reverse split is a necessary step to attract institutional investors who avoid penny stocks, and that the large authorized share pool is a war chest for strategic acquisitions—perhaps to acquire more Solana assets or build ecosystem infrastructure. The June 2024 issuance of 1.16 billion shares for an acquisition shows that the company is willing to use equity as currency. In theory, if the company makes a transformative acquisition that significantly increases its Solana holdings, the dilution could be offset by the appreciation of the underlying SOL assets. But the counterpoint is stark: the company’s market cap is below $15 million. It has been delisted from the NYSE. It trades on OTC Pink, which has minimal disclosure requirements. The management team’s track record is one of aggressive equity issuance—the June acquisition alone represented 37.5% of the pre-split issued shares. There is no evidence that the company’s Solana treasury strategy has generated any operational revenue or that the management holds a meaningful stake that aligns with minority shareholders. The “Solana treasury” narrative is a marketing label, not a verifiable asset strategy. The balance sheet does not lie. The press release does.
Takeaway
SOLAI’s capital structure is a ticking time bomb. The 22,675x authorized-to-issued ratio is not a temporary anomaly. It is a deliberate design for future dilution. The only question is when the trigger is pulled—and whether the company’s Solana holdings will be used to justify the issuance. For existing holders, the risk is not just dilution; it is the complete erosion of economic value. For the Solana ecosystem, this company is a reputational liability—a poorly governed, publicly traded vehicle that uses the “Solana treasury” tag to attract capital while preparing to dilute it. The market has already priced in the risk: a market cap below $15 million and a ticker on OTC Pink. The restructuring does not change the trajectory. It accelerates it. Read the code, not the pitch deck. In this case, read the charter, not the press release. The math is the truth. The narrative is the distraction.